- ►annals.org [PDF] S Kubo, S Nishiguchi, K Hirohashi, H Tanaka, … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Interferon therapy decreases the incidence of hep- atocellular
carcinoma in patients with chronic hepatitis C. Objective: To evaluate effects
of interferon- on recurrence after resection of hepatitis C virus–related ... Cited by 159 - Related articles - BL Direct - All 5 versions
K Ikeda, Y Arase, S Saitoh, M Kobayashi, Y … - Hepatology, 2000 - interscience.wiley.com Because hepatocellular carcinoma often recurs after surgical resection or
ethanol injection therapy, we conducted a prospective randomized controlled
trial of interferon (IFN) in patients with chronic liver disease caused by ... Cited by 208 - Related articles - BL Direct - All 3 versions
SM Lin, CJ Lin, CW Hsu, DI Tai, IS Sheen, DY … - CA A Cancer Journal for Clinicians - interscience.wiley.com To evaluate the effectiveness of interferon-alpha (IFN- ) in preventing HCC
recurrence, 30 eligible patients were randomized into three groups: 11 patients
treated with three mega units (MU) of IFN- three times weekly for 24 months ... Cited by 59 - Related articles - BL Direct - All 3 versions
S Kubo, S Nishiguchi, K Hirohashi, H Tanaka, … - British Journal of Surgery, 2002 - ingentaconnect.com Background: Interferon therapy seems to decrease the incidence of recurrence
after resection of hepatitis C virus (HCV)-related hepatocellular carcinoma
(HCC). Effects of postoperative interferon therapy on the survival rate ... Cited by 71 - Related articles - BL Direct - All 4 versions
V Mazzaferro, R Romito, M Schiavo, L Mariani, … - Hepatology, 2006 - formazione.eu.com Abbreviations: HCC, hepatocellular carcinoma; IFN, interferon; HCV, hepatitis C
virus; HBV, hepatitis B virus; anti-HBc, hepatitis B anticore antibody; RCT,
randomized controlled trial; RFS, recurrence-free survival; DSS, disease- ... Cited by 46 - Related articles - View as HTML - BL Direct - All 4 versions
SNATS Kubob - Prevention of Occurrence and Recurrence of Human …, 2005 - books.google.com Intervirology 2005; 48: 71-75 DOI: 10.1159/000082098 Effect of Long-Term
Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate
after Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma ... Cited by 14 - Related articles - All 6 versions
- ►annals.org [PDF] Y Shiratori, Y Ito, O Yokosuka, F Imazeki, R … - Annals of internal medicine, 2005 - Am Coll Physicians Patients: 345 patients with chronic hepatitis C and cirrhosis enrolled in
previous trials. Intervention: 271 patients received 6 to 9 million U of inter-
feron 3 times weekly for 26 to 88 weeks; 74 received no treat- ment. ... Cited by 85 - Related articles - All 5 versions
S Shiina, T Teratani, S Obi, K Hamamura, Y … - Oncology, 2002 - ncbi.nlm.nih.gov Treatment of hepatocellular carcinoma (HCC) is different from that of other
solid tumors, in that surgery plays a limited role while nonsurgical therapies
are very instrumental. At our institute, 90% of previously untreated ... Cited by 109 - Related articles - BL Direct - All 5 versions
JM Llovet, M Sala, L Castells, Y Suarez, R … - Hepatology, 2000 - interscience.wiley.com The aim of this randomized controlled trial was to assess the efficacy of
interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma
(HCC). Fifty-eight patients with HCC who were not suitable for resection, ... Cited by 161 - Related articles - BL Direct - All 3 versions
